Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - In-house Corporation

Solvay Pharma Inc. / Barry Hayter, President & Chief Excutive Officer

Registration Information

In-house Corporation name: Solvay Pharma Inc.
Responsible Officer Name: Barry Hayter, President & Chief Excutive Officer 
Responsible Officer Change History
Initial registration start date: 2006-09-25
Registration status: Inactive
Registration Number: 743414-13775

Associated Communications

Total Number of Communication Reports: 1

Monthly communication reports in the last 6 months: 0

Version 10 of 10 (2009-04-01 to 2009-12-22)

Version 10 of 10 (2009-04-01 to 2009-12-22)



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

Solvay Pharma Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
Solvay Pharma Inc. 2008-08-14 2009-12-22

The following names have been used before July 2, 2008

  • Solvay Pharma Inc.

Responsible Officer Change History

Solvay Pharma Inc.

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)
Barry Hayter 2009-04-01 2009-12-22
Graham Jobson 2006-09-25 2009-07-01

All Monthly Communication Reports for Solvay Pharma Inc.

Barry Hayter, President & Chief Excutive Officer (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-1 of 1

  • Solvay Pharma Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brien Benoit, Chair | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Industry, Science and Technology, Health, Consumer Issues
    Communication date: 2008-10-21
    Posted date: 2008-11-18
    Communication number: 13775-85758 View associated registration

Public offices held:


Date Modified: